New Drug Approved for Neuroblastoma Based on MSKCC Research ...Middle East

Naxitamab has been approved for pediatric and adult patients with relapsed/refractory neuroblastoma in the bone and bone marrow that has responded to prior therapy. FDA Approvals

Read More Details
Finally We wish PressBee provided you with enough information of ( New Drug Approved for Neuroblastoma Based on MSKCC Research )

Also on site :

• Possible tornado in Phelps on Monday
• Evacuations ordered after brush fire breaks out in Laguna Beach
• Photos: A blaze at Cairo telecommunications building causes service disruptions